Publikationen von Y. Genzel

Roedig, J.; Rapp, E.; Genzel, Y.; Reichl, U.: Impact of different influenza cultivation conditions on HA N-glycosylation. In BMC Proceedings, 5 (S8 ), P113. 22nd European Society for Animal Cell Technology (ESACT) Meeting on Cell Based Technologies , Vienna, Austria, 15. Mai 2011 - 18. Mai 2011. (2011)

Vester, D.; Rapp, E.; Kluge, S.; Genzel, Y.; Reichl, U.: Virus-Wirtszell-Interaktion bei der Produktion von Influenza A Impfstoff in tierischer Zellkultur: Änderungen des Proteoms von Produktionszelllinien. In Chemie Ingenieur Technik, 82 (9 - Special Issue : ProcessNet-Jahrestagung 2010 und 28. Jahrestagung der Biotechnologen), S. 1496. ProcessNet-Jahrestagung 2010 und 28. Jahrestagung der Biotechnologen, Aachen, Germany, 21. September 2010 - 23. September 2010. (2010)

Öncül, A.; Kalmbach, A.; Genzel, Y.; Reichl, U.; Thevenin, D.: Numerische und experimentelle Untersuchung der Fließbedingungen in Wave-Bioreaktoren. In Chemie-Ingenieur-Technik, 81 (8), S. 1241 . ProcessNet-Jahrestagung 2009 und 27. Jahrestagung der Biotechnologen, Mannheim, Germany, 08. September 2009 - 10. September 2009. Verlag Chemie, GmbH, Weinheim, Germany (2009)

Sidorenko, Y.; Dauner, M.; Genzel, Y.; Reichl, U.: Metabolic Flux Analysis of MDCK Cells in Glutamine-Containing and Glutamine-Free Culture Media. In Metabolic Engineering VI: Program, S. 102. Metabolic Engineering IV, Noordwijkerhout, The Netherlands, 01. Oktober 2006 - 05. Oktober 2006. (2006)

Pelz, L.; Rüdiger, D.; Hein, M.; Böhme, J.; Bälkner, M.; Kershaw, O.; Marichal-Gallardo, P.; Gruber, A.; Genzel, Y.; Bruder, D. et al.; Kupke, S. Y.; Reichl, U.: Engineered defective interfering particles of influenza A virus for antiviral treatment. 33^rd Annual Meeting of the Society for Virology (GfV), Vienna (Austria) (2024)

Dogra, T.; Pelz, L.; Boehme, J. D.; Baelkner, M.; Kershaw, O.; Marichal-Gallardo, P.; Gruber, A. D.; Genzel, Y.; Bruder, D.; Kupke, S. Y. et al.; Reichl, U.: Genetically engineered defective interfering particles of influenza A virus for antiviral treatment and vaccination. 17^th Vaccine Congress, Glasgow (Scotland) (2023)

Genzel, Y.: ESACT Course on Cell Culture-based Viral Vaccines (8^th Edition): Exercise on vaccine design. ESACT Course 2023, Llafranc (Spain) (2023)

Genzel, Y.: ESACT Course on Cell Culture-based Viral Vaccines (8^th Edition): Overview on COVID-19 candidate vaccines. Introduction Exercise. ESACT Course 2023, Llafranc (Spain) (2023)

Genzel, Y.: ESACT Course on Cell Culture-based Viral Vaccines (8^th Edition):Upstream Process Intensification. ESACT Course 2023, Llafranc (Spain) (2023)

Genzel, Y.: ESACT Course on Cell Culture-based Viral Vaccines (8^th Edition):Upstream Process Development - From Master Seed to Production. ESACT Course 2023, Llafranc (Spain) (2023)

Genzel, Y.; Zinnecker, T. M.; Göbel, S.; Reichl, U.: Intensified cell-based virus production: A process development challenge for multiple cell-virus combinations. 16^th PEACe Conference, Sitges (Spain) (2023)

Genzel, Y.; Zinnecker, T. M.; Göbel, S.; Reichl, U.: Next-Generation Virus Production: From Clone, to AMBR, to Perfusion and Very High Virus Yield. International Society for Vaccines (ISV) Annual Congress, Lausanne (Switzerland) (2023)

Genzel, Y.; Zinnecker, T. M.; Göbel, S.; Reichl, U.: Increase in supply through use of new technologies for high yield vaccines. Flanders Vaccine, Brussels (Belgium) (2023)

Göbel, S.; Dallmeier, K.; Jordan, I.; de Jong, J.; Reichl, U.; Genzel, Y.: Intensified production for a yellow fever - ZIKA virus vaccine candicate. Democratization of biotherapies: new manufacturing modalities and intensification's, Oxford, UK (2023)

Göbel, S.; Jaén, K. E.; Pelz, L.; Reiter , M.; Altomonte, J.; Reichl, U.; Genzel, Y.: Intensifiying OSB processes for high titer virus production. 5^th large scale meeting: Orbital shaken bioreactors, Girona (Spain) (2023)

Küchler, J.; Opitz, P.; Rüdiger, D.; Kupke, S. Y.; Genzel, Y.; Benndorf, D.; Reichl, U.: Absolute quantification of influenza A virus proteins during single-round replication in different host cells. 6^th Workshop on Virus Dynamics, Nagoya (Japan) (2023)

Pelz, L.; Dogra, T.; Boehme, J.D.; Hein, M. D.; Marichal-Gallardo, P.; Genzel, Y.; Bruder, D.; Kupke, S. Y.; Reichl, U.: Influenza A virus OP7 defective interfering particles: Cell culture-based production and antiviral efficacy in vivo. Cell Culture Engineering (CCE) XVIII , Cancun (Mexico) (2023)

Pelz, L.; Genzel, Y.; Kupke, S. Y.; Reichl, U.: In-depth characterization and cell culture-based production of influenza A virus defective interfering particles. ACTIP fellowship session, Dublin (Ireland) (2023)

Pelz, L.; Rüdiger, D.; Dogra, T.; Alnaji, F. D.; Genzel, Y.; Brooke, C. B.; Kupke, S. Y.; Reichl, U.: Semi-continuous Propagation of Influenza A Virus and Its Defective Interfering Particles: Analyzing the Dynamic Competition To Select Candidates for Antiviral Therapy. Vir-AI-DIP Workshop, Hamburg (Germany) (2023)

Zinnecker, T. M.; Badri, N.; Araujo, D.; Hinkelmann, A.; Thiele, K.; Reichl, U.; Genzel, Y.: Novel approach towards vaccine manufacturing: from single-cell cloning to high-yielding influenza virus production. 4^th Global Bioprocessing, Bioanalytics and ATMP Manufacturing Congress, Dublin (Ireland) (2023)